首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

輸液治療市場規模、佔有率和成長分析（按產品、適應症、治療方法、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898059

輸液治療市場規模、佔有率和成長分析（按產品、適應症、治療方法、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Infusion Therapy Market Size, Share, and Growth Analysis, By Product (Infusion Pumps, Infusion Set), By Indication (Cancer, Gastrointestinal Diseases/Disorders), By Therapy, By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球輸液治療市場規模將達到 474.3 億美元，到 2025 年將達到 506.1 億美元，到 2033 年將達到 850.2 億美元，預測期（2026-2033 年）的複合年成長率為 6.7%。

由於人口老化、慢性病盛行率上升以及輸液技術的進步，全球輸液治療市場正經歷顯著成長。該市場能夠將藥物直接有效地輸送到血液中，確保精準給藥並最大限度地減少副作用，從而有助於改善治療效果。輸液治療用途廣泛，涵蓋多種應用，包括藥物和必需營養素的輸注。它通常在門診進行，從而降低住院成本。然而，潛在的併發症，例如感染風險和對專業操作人員的需求，也可能帶來挑戰。隨著對有效醫療解決方案的需求不斷成長，尤其是在居家醫療領域，輸液治療市場預計將持續成長，因為它對患者照護的創新和效率做出了重大貢獻。

全球輸液治療市場促進因素

慢性疾病（包括癌症、糖尿病和心血管疾病）發生率的不斷上升，顯著增加了對輸液治療產品和服務的需求。隨著越來越多的人面臨這些長期健康挑戰，醫療服務提供者越來越依賴先進的輸液解決方案來有效輸送必需的藥物和營養素。這種對輸液治療日益成長的依賴反映了整個醫療保健領域的更廣泛趨勢，即個人化和高效的治療方案對於管理複雜疾病至關重要。因此，在輸液治療在改善患者預後和提高醫療品質方面發揮的關鍵作用的推動下，該市場正經歷強勁成長。

全球輸液治療市場面臨的限制因素

全球輸液治療市場面臨的一大挑戰是輸液治療產品和服務的高成本。這個問題在開發中國家醫療資源匱乏，阻礙了這些必要療法的普及。由於醫療體系面臨財務壓力，輸液治療的高昂成本可能會使病患和醫療服務提供者都不願使用這些關鍵服務。因此，在資源匱乏地區，輸液治療的成本效益仍是改善病患就醫途徑和確保有效治療的關鍵因素。解決此限制因素對於市場成長和改善醫療效果至關重要。

全球輸液治療市場趨勢

全球輸液治療市場正經歷著向居家醫療解決方案的顯著轉變，這主要得益於患者對居家輸液治療日益成長的偏好。這一趨勢凸顯了患者對便利性、舒適性和成本效益的需求，促使他們更傾向於在熟悉且充滿支持的環境中接受醫療程序。隨著醫療保健系統日益重視以患者為中心的模式，輸液治療領域也不斷調整以滿足對便利居家照護服務的需求，從而推動了創新技術和攜帶式設備的發展。這種轉變不僅改善了患者的治療效果，也促使醫療服務提供者拓展服務範圍，從而改變了傳統的靜脈輸液治療模式。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- Option Care Health Inc.（美國）
- 百特國際有限公司（美國）
- ICU Medical, Inc.（美國）
- B.Braun Melsungen AG（德國）
- 泰爾茂株式會社（日本）
- 穆格公司（美國）
- 費森尤斯股份公司（德國）
- 史密斯醫療（英國）
- JMS株式會社（日本）
- 凱撒利亞醫療電子（以色列）
- CareFusion公司（美國）
- Poly Medicure Limited（印度）
- 日本尼普洛株式會社
- 美敦力公司（愛爾蘭）
- 貝克頓·迪金森公司（BD）（美國）
- 3M公司（美國）
- 泰利福公司（美國）
- 愛德華生命科學公司（美國）
- 科樂普公司（丹麥）
- 康維泰克Group Limited（英國）

結論與建議

簡介目錄

Product Code: SQMIG35B2080

Global Infusion Therapy Market size was valued at USD 47.43 Billion in 2024 and is poised to grow from USD 50.61 Billion in 2025 to USD 85.02 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global infusion therapy market is experiencing significant growth, propelled by an aging population, the rising incidence of chronic diseases, and advancements in infusion technology. This market segment allows for efficient administration of medications directly into the bloodstream, facilitating precise dosing while minimizing side effects and enhancing treatment outcomes. Infusion therapy is versatile, encompassing various applications, including the delivery of medications and essential nutrients, and often occurs in outpatient settings, which can lower hospitalization costs. However, potential complications such as infection risks and the need for skilled administration can pose challenges. As the demand for effective healthcare solutions rises, especially within home healthcare contexts, the infusion therapy market is anticipated to thrive, contributing greatly to patient care innovations and efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segments Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The rising incidence of chronic illnesses, including cancer, diabetes, and cardiovascular conditions, has significantly heightened the need for infusion therapy products and services. As more individuals face these long-term health challenges, healthcare providers are increasingly turning to advanced infusion solutions to deliver essential medications and nutrients effectively. This growing reliance on infusion therapy reflects a broader trend in healthcare, where tailored and efficient treatment options are becoming crucial for managing complex conditions. Consequently, the infusion therapy market is experiencing robust growth driven by the essential role these therapies play in improving patient outcomes and enhancing the quality of care.

Restraints in the Global Infusion Therapy Market

A significant challenge facing the Global Infusion Therapy market is the elevated costs linked to infusion therapy products and services. This issue is particularly pronounced in developing nations, where limited healthcare access can hinder the adoption of these essential treatments. As financial constraints impact healthcare systems, the high expenses associated with infusion therapy may deter both patients and healthcare providers from utilizing these vital services. Consequently, the affordability of infusion therapy remains a crucial factor for improving patient access and ensuring effective treatment in regions where resources are scarce. Addressing this restraint is essential for market growth and improved healthcare outcomes.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is witnessing a notable shift towards home-based healthcare solutions, driven by rising patient preference for home infusion therapy. This trend emphasizes the desire for convenience, comfort, and cost-effectiveness, leading to a greater inclination for receiving medical treatment in familiar and supportive environments. As healthcare systems increasingly prioritize patient-centered approaches, the infusion therapy segment is adapting to meet demands for accessible home care services, bolstering growth in innovative technologies and portable devices. This transition not only enhances patient outcomes but also prompts healthcare providers to expand their services, thereby transforming the traditional landscape of intravenous therapy delivery.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2026-2033)

Market Overview
Infusion Pumps
- Ambulatory Infusion Pumps
- Stationary Infusion Pumps
- Syringe Infusion Pumps
- Disposable Pumps
- Large Volume Pumps
- Elastomeric pumps
Infusion Set
Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2026-2033)

Market Overview
Cancer
Gastrointestinal Diseases/Disorders
Congestive Heart Failure
Rheumatoid Arthritis
Hemophilia
Immune Deficiencies
Others

Global Infusion Therapy Market Size by Therapy & CAGR (2026-2033)

Market Overview
Antibiotic/Antiviral
Anti-coagulation
Anti-emetics
Blood Component Stimulating Factor
Chemotherapy
Nutrition
Hydration
Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Chemotherapy
Diabetes
Gastrointestinal Diseases
Pain management
Others

Global Infusion Therapy Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Clinics
Homecare Settings

Global Infusion Therapy Market Size & CAGR (2026-2033)

North America (Product, Indication, Therapy, Application, End-user)
- US
- Canada
Europe (Product, Indication, Therapy, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Indication, Therapy, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Indication, Therapy, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Indication, Therapy, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Option Care Health Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moog Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JMS Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caesarea Medical Electronics (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareFusion Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poly Medicure Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Convatec Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments